XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.8.0.1

5) Stock-based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2018
Notes |
5) Stock-based Compensation | 5) Stock Compensation Plans The Company has four fixed option plans (the “2003 Plan”, the “2006 Director Plan”, the “2013 Plan” and the “2014 Director Plan”). Compensation expense for options issued of $58,087 and $101,996 has been recognized for these plans for the three months ended March 31, 2018 and 2017, respectively. As of March 31, 2018, the total unrecognized compensation expense related to the options issued was $155,658, which is expected to be recognized over the vesting period of one year. The fair value of each option granted is estimated on the date of grant using the Black Scholes Option Pricing Model. The Company estimates the expected life of the options using the simplified method. Future volatility is estimated based upon the weighted historical volatility of the Company’s Class A common stock over a period equal to the expected life of the options. The risk-free interest rate for the expected life of the options is based upon the Federal Reserve Board’s daily interest rates in effect at the time of the grant. A summary of the status of the Company’s stock compensation plans as of March 31, 2018, and the changes during the three months ended March 31, 2018, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at December 31, 2017 |  | 880,426 |  | $ 4.35 |  | 523,603 |  | $ 5.24
Granted |  | - |  |  |  | - |  |
Exercised |  | (31,984) |  |  |  | - |  |
Cancelled |  | (5,704) |  |  |  | - |  |
Outstanding at March 31, 2018 |  | 842,738 |  | $ 4.48 |  | 523,603 |  | $ 5.24
As of March 31, 2018: |  |  |  |  |  |  |  |
Options exercisable |  | 744,686 |  | $ 4.40 |  | 468,477 |  | $ 5.29
As of March 31, 2018: |  |  |  |  |  |  |  |
Available options for future grant |  | 421,241 |  |  |  | 165,638 |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
outstanding at March 31, 2018 |  | 6.55 years |  |  |  | 3.19 years |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
exercisable at March 31, 2018 |  | 6.53 years |  |  |  | 2.43 years |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
outstanding at March 31, 2018 (1) |  | $850,528 |  |  |  | $251,961 |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
exercisable at March 31, 2018 (1) |  | $836,882 |  |  |  | $232,667 |  |
(1) The Company used a stock price of $5.15 as of March 31, 2018 to derive intrinsic value.
A summary of the status of the Company’s stock compensation plans as of March 31, 2017, and the changes during the three months ended March 31, 2017, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at December 31, 2016 |  | 741,973 |  | $ 4.33 |  | 556,298 |  | $ 4.61
Granted |  | - |  |  |  | - |  |
Exercised |  | - |  |  |  | - |  |
Cancelled |  | - |  |  |  | - |  |
Outstanding at March 31, 2017 |  | 741,973 |  | $ 4.33 |  | 556,298 |  | $ 4.61
As of March 31, 2017: |  |  |  |  |  |  |  |
Options exercisable |  | 636,764 |  | $ 3.94 |  | 493,298 |  | $ 4.26
As of March 31, 2017: |  |  |  |  |  |  |  |
Available options for future grant |  | 253,432 |  |  |  | - |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
outstanding at March 31, 2017 |  | 7.12 years |  |  |  | 2.42 years |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |
exercisable at March 31, 2017 |  | 6.70 years |  |  |  | 2.13 years |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
outstanding at March 31, 2017 (1) |  | $1,837,828 |  |  |  | $1,264,540 |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |
exercisable at March 31, 2017 (1) |  | $1,824,086 |  |  |  | $1,264,540 |  |
(1) The Company used a stock price of $6.80 as of March 31, 2017 to derive intrinsic value.
The total intrinsic value (which is the amount by which the fair value of the underlying stock exceeds the exercise price of an option on the exercise date) of stock options exercised during the three months March 31, 2018 and 2017 was $111,157 and $-0-, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration